Polymer Capital Management US LLC Invests $229,000 in Molina Healthcare, Inc. (NYSE:MOH)

Polymer Capital Management US LLC acquired a new stake in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 788 shares of the company's stock, valued at approximately $229,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in MOH. Wellington Management Group LLP grew its holdings in shares of Molina Healthcare by 7.4% during the fourth quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock worth $766,111,000 after purchasing an additional 181,073 shares during the last quarter. FMR LLC raised its stake in shares of Molina Healthcare by 31.1% during the fourth quarter. FMR LLC now owns 1,801,113 shares of the company's stock valued at $524,214,000 after acquiring an additional 427,276 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Molina Healthcare by 2.5% during the fourth quarter. Geode Capital Management LLC now owns 1,436,909 shares of the company's stock worth $417,144,000 after purchasing an additional 34,992 shares during the period. Norges Bank acquired a new stake in Molina Healthcare in the fourth quarter valued at $134,675,000. Finally, Charles Schwab Investment Management Inc. lifted its holdings in Molina Healthcare by 2.6% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 400,080 shares of the company's stock worth $116,443,000 after buying an additional 10,002 shares during the period. 98.50% of the stock is currently owned by institutional investors.

Insider Activity

In related news, Director Steven J. Orlando sold 1,000 shares of the firm's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total transaction of $301,330.00. Following the completion of the transaction, the director now owns 17,375 shares of the company's stock, valued at $5,235,608.75. This trade represents a 5.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 1.10% of the company's stock.

Remove Ads

Molina Healthcare Stock Performance

Molina Healthcare stock traded up $0.94 during midday trading on Monday, reaching $345.94. 111,696 shares of the company traded hands, compared to its average volume of 652,568. The firm has a market capitalization of $18.92 billion, a price-to-earnings ratio of 16.93, a price-to-earnings-growth ratio of 1.06 and a beta of 0.70. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.62 and a quick ratio of 1.62. The business has a 50 day moving average of $310.39 and a two-hundred day moving average of $307.97. Molina Healthcare, Inc. has a 12 month low of $262.32 and a 12 month high of $373.22.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. As a group, research analysts predict that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the stock. Guggenheim initiated coverage on shares of Molina Healthcare in a research report on Wednesday, April 9th. They issued a "neutral" rating on the stock. Barclays reduced their price objective on shares of Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating for the company in a research report on Friday, February 7th. Mizuho upped their target price on Molina Healthcare from $376.00 to $400.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $350.00 price objective (down from $378.00) on shares of Molina Healthcare in a research note on Tuesday, December 17th. Finally, UBS Group cut their price target on shares of Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a report on Friday, February 7th. Seven analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $355.75.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.